DE2905649A1 - Neue aminozucker-derivate, ihre herstellung und verwendung als amylasehemmende mittel - Google Patents

Neue aminozucker-derivate, ihre herstellung und verwendung als amylasehemmende mittel

Info

Publication number
DE2905649A1
DE2905649A1 DE19792905649 DE2905649A DE2905649A1 DE 2905649 A1 DE2905649 A1 DE 2905649A1 DE 19792905649 DE19792905649 DE 19792905649 DE 2905649 A DE2905649 A DE 2905649A DE 2905649 A1 DE2905649 A1 DE 2905649A1
Authority
DE
Germany
Prior art keywords
trestatin
brown
see
trestatins
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19792905649
Other languages
German (de)
English (en)
Inventor
Kiyoshi Ogawa
Yasuji Suhara
Kimihiro Watanabe
Kazuteru Yokose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2905649A1 publication Critical patent/DE2905649A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE19792905649 1978-02-14 1979-02-14 Neue aminozucker-derivate, ihre herstellung und verwendung als amylasehemmende mittel Withdrawn DE2905649A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (1)

Publication Number Publication Date
DE2905649A1 true DE2905649A1 (de) 1979-08-16

Family

ID=9803510

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19792905649 Withdrawn DE2905649A1 (de) 1978-02-14 1979-02-14 Neue aminozucker-derivate, ihre herstellung und verwendung als amylasehemmende mittel
DE7979100441T Expired DE2962165D1 (en) 1978-02-14 1979-02-14 New amino sugar derivatives, their preparation and amylase inhibitors containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE7979100441T Expired DE2962165D1 (en) 1978-02-14 1979-02-14 New amino sugar derivatives, their preparation and amylase inhibitors containing them

Country Status (26)

Country Link
US (1) US4273765A (cg-RX-API-DMAC7.html)
EP (1) EP0003616B1 (cg-RX-API-DMAC7.html)
JP (1) JPS54163511A (cg-RX-API-DMAC7.html)
AR (1) AR219150A1 (cg-RX-API-DMAC7.html)
AT (1) AT367451B (cg-RX-API-DMAC7.html)
AU (1) AU527318B2 (cg-RX-API-DMAC7.html)
CA (1) CA1121290A (cg-RX-API-DMAC7.html)
DE (2) DE2905649A1 (cg-RX-API-DMAC7.html)
DK (1) DK149599C (cg-RX-API-DMAC7.html)
ES (1) ES477653A1 (cg-RX-API-DMAC7.html)
FI (1) FI63062C (cg-RX-API-DMAC7.html)
FR (1) FR2416901A1 (cg-RX-API-DMAC7.html)
GR (1) GR72817B (cg-RX-API-DMAC7.html)
HU (1) HU181442B (cg-RX-API-DMAC7.html)
IE (1) IE47916B1 (cg-RX-API-DMAC7.html)
IL (1) IL56626A0 (cg-RX-API-DMAC7.html)
LU (1) LU80906A1 (cg-RX-API-DMAC7.html)
MC (1) MC1253A1 (cg-RX-API-DMAC7.html)
NL (1) NL7901182A (cg-RX-API-DMAC7.html)
NO (1) NO153011C (cg-RX-API-DMAC7.html)
NZ (1) NZ189625A (cg-RX-API-DMAC7.html)
PH (1) PH15084A (cg-RX-API-DMAC7.html)
PT (1) PT69218A (cg-RX-API-DMAC7.html)
SE (1) SE7901276L (cg-RX-API-DMAC7.html)
YU (1) YU41437B (cg-RX-API-DMAC7.html)
ZA (1) ZA79528B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056194A1 (en) 1981-01-05 1982-07-21 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
ES2083152T3 (es) * 1990-11-30 1996-04-01 Monoclonetics Int Metodos para el diagnostico de dolores cronicos lumbares y cervicales.
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
IL143225A (en) * 2000-05-24 2008-03-20 Pfizer Preparation of drugs containing α-amylase inhibitors to treat hyperacidity of the inner abdomen
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
ES2328384T3 (es) * 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CN101998998A (zh) * 2008-04-11 2011-03-30 安斯泰来制药株式会社 氨基糖化合物及其生产方法
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
WO2011145022A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
AU2017342083A1 (en) 2016-10-14 2019-04-11 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
EP3883930A1 (en) 2018-11-20 2021-09-29 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056194A1 (en) 1981-01-05 1982-07-21 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
US4701559A (en) * 1981-01-05 1987-10-20 Takeda Chemical Industries, Inc. N-substituted pseudo-aminosugars, their production and use
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
YU41437B (en) 1987-06-30
DE2962165D1 (en) 1982-03-25
EP0003616B1 (de) 1982-02-24
ES477653A1 (es) 1980-03-01
EP0003616A3 (en) 1979-09-05
US4273765A (en) 1981-06-16
AT367451B (de) 1982-07-12
AU527318B2 (en) 1983-02-24
LU80906A1 (de) 1980-09-24
JPS54163511A (en) 1979-12-26
FR2416901B1 (cg-RX-API-DMAC7.html) 1980-10-24
AR219150A1 (es) 1980-07-31
MC1253A1 (fr) 1980-01-14
FI63062B (fi) 1982-12-31
CA1121290A (en) 1982-04-06
DK61179A (da) 1979-08-15
SE7901276L (sv) 1979-08-15
DK149599C (da) 1987-06-01
IE47916B1 (en) 1984-07-25
NL7901182A (nl) 1979-08-16
IL56626A0 (en) 1979-05-31
GR72817B (cg-RX-API-DMAC7.html) 1983-12-06
PH15084A (en) 1982-07-02
DK149599B (da) 1986-08-04
ZA79528B (en) 1980-02-27
PT69218A (en) 1979-03-01
YU34879A (en) 1983-01-21
ATA108879A (de) 1981-11-15
FR2416901A1 (fr) 1979-09-07
IE790274L (en) 1979-08-14
HU181442B (en) 1983-07-28
JPS643877B2 (cg-RX-API-DMAC7.html) 1989-01-23
NO153011B (no) 1985-09-23
NO790469L (no) 1979-08-15
NO153011C (no) 1986-01-02
FI63062C (fi) 1983-04-11
EP0003616A2 (de) 1979-08-22
FI790486A7 (fi) 1979-08-15
AU4402879A (en) 1979-08-23
NZ189625A (en) 1981-05-01

Similar Documents

Publication Publication Date Title
EP0003616B1 (de) Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
DE2347782C3 (de) Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CH666043A5 (de) Glycosid-antibiotika und verfahren zu ihrer herstellung.
KR870001373B1 (ko) 항생물질 BMG 162-aF2의 제조방법
DE1957980C3 (de) Verfahren zur Herstellung von Daunorubicin durch Züchtung eines Streptomyces
DE2209834C3 (de) Herstellung von Saccharase-Inhibitoren
DE3035193C2 (de) Antibiotikum SF-1130-x↓3↓, Verfahren zu dessen Herstellung und dieses Antibiotikum enthaltende Arzneimittel
CH635616A5 (de) Verwendung von organismen der familie bacillaceae zur gewinnung von inhibitoren fuer glykosid-hydrolasen.
EP0019302A1 (de) Neue tetracyclische Verbindungen, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
EP0236894B1 (de) Efomycin G, seine Herstellung und seine Verwendung als Leistungsförderer bei Tieren
DE2556043C3 (de) Antibiotikum Bu-2183, Verfahren zu seiner Herstellung und Arzneimittel
DE2209833C3 (de) Herstellung eines Amylaseinhibitors
CH633043A5 (en) Process for preparing aminosugar derivatives
EP0259751A2 (de) Annomycin, ein Antibiotikum; mikrobiologisches Verfahren zu dessen Herstellung und seine Verwendung
EP0304400B1 (de) Phenanthridinderivate, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
DE3511753A1 (de) Verwendung von efomycinen als wachstumsfoerderer, efomycine und ihre herstellung
DE2903710A1 (de) Neue amylase-inhibitoren und verfahren zu deren herstellung
EP0173948A2 (de) Neue Pseudooligosaccharide mit alpha-Glukosidase-hemmender Wirkung, Verfahren zur deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE2726899C1 (cg-RX-API-DMAC7.html)
DE2028986C3 (de) Selenomycm
DE2510868C3 (de) Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B
AT216143B (de) Verfahren zur Herstellung eines neuen Antibiotikums
KR830001068B1 (ko) 아미노당 유도체의 제조방법
DE2366210C2 (de) Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel

Legal Events

Date Code Title Description
8141 Disposal/no request for examination